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Research
Population-based studies have shown
higher incidences of epilepsy in developing
countries, with the age-adjusted incidence
ranging from 64 to 190 per 100 000 person-
years,2-6 hile that in developed countries is
lower, at 24 to 53 per 100 000 person-








Objective:  To compare patterns of epilepsy in Indigenous and non-Indigenous people 
presenting to hospital.
Study design:  Retrospective cross-sectional survey of individuals admitted to hospital 
with a diagnosis of epilepsy (1 January 2001 – 31 December 2004); presenting to the 
emergency department with a seizure (2004); or presenting to the epilepsy clinic 
ptember 2002 – 31 March 2005).
ng:  Cairns Base Hospital, the major referral centre for Far North Queensland, 
ding Cape York and the Torres Strait, with a population of 230 000 (13% Indigenous).
 outcome measures:  Proportion of Indigenous patients presenting for epilepsy; 
ortion of Indigenous and non-Indigenous groups affected by each of the main 
psy syndromes.
lts:  Of 359 patients attending the epilepsy clinic and 918 patients having 
electroencephalography (EEG), 11% and 13% were Indigenous, respectively (in 
proportion with the catchment population). However, 30% (146/486) of patients 
presenting to the emergency department with seizure, 31% (130/418) of inpatient 
admissions with epilepsy, and 44% (28/63) of patients admitted with status epilepticus 
were Indigenous. Indigenous patients were more likely to have an abnormal EEG result 
(P = 0.025), while non-Indigenous patients presenting to the clinic were more likely to be 
classified as non-epileptic (31% v 18%). In those with abnormal EEG, the frequency 
distribution of abnormalities was similar, and, in those with epilepsy, syndrome 
classification also showed similar frequencies. There was no significant difference in 
occurrence of epileptogenic abnormalities detected by imaging (13% non-Indigenous v 
18% Indigenous) or in alcohol consumption (38% v 37%).
Conclusions:  Indigenous Australians have similar epilepsy syndromes to the non-
Indigenous population, but they present with more serious disease. This discrepancy 
may relate to inequitable health care utilisation due to cultural issues or geographic 
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Str
higA tralian Aboriginals and Torresait Islanders are burdened withher rates of many chronic ill-
nesses, most notably diabetes, vascular dis-
ease and renal failure.1 However, there is
limited information regarding epilepsy in
these populations.
studies have been performed. The most
commonly cited hypothesis to explain this
incidence difference is a higher rate of infec-
tious diseases in developing countries (eg,
those causing cerebral tuberculosis or
neurocysticercosis).11,12
The health status of Australia’s Indigenous
population is in many respects more typical
of that in developing countries.13 However,
in contrast to the situation in many develop-
ing nations, Indigenous Australians have a
full range of health care services available to
them, including a comprehensive range of
neurological investigations — neurological
assessment, electroencephalography (EEG),
and cerebral imaging, including computed
tomography (CT) and magnetic resonance
imaging (MRI). However, geographic isola-
tion and cultural issues lead to persisting
inequalities in health care utilisation. Gov-
ernment strategies attempt to overcome this
through subsidised transport from remote
regions to major centres, and “outreach”
medical clinics, where doctors visit remote
communities by plane.
Cairns Base Hospital (CBH) in Far North
Queensland serves a vast and mostly sparsely
populated area about the same size as Victoria
or the United Kingdom. Of the population of
230000, of whom 135 000 live in Cairns and
its immediate surrounds, 13% are Indi-
genous.14 The hospital’s catchment area
extends to the Torres Strait, 1000km away.
The only specialist neurological services for
the region are at CBH, which also provides
the only EEG, CT and MRI services. These
are available free of charge to all patients.
Our aim was to compare patterns of
epilepsy in Indigenous and non-Indigenous
people presenting to CBH.
METHODS
Data sources
Epilepsy cases were identified from several
overlapping sources. We reviewed hospital
discharge diagnoses, emergency department
(ED) diagnoses, epilepsy clinic classifica-
tions and EEG classifications, comparing
Indigenous and non-Indigenous patients.
Patients of all ages were included in the
study.
Hospital and ED data
Hospital discharge coding data were
searched for all patients with an admission
diagnosis of epilepsy or status epilepticus
from 1 January 2001 to 31 December 2004.
These figures were compared with overall
hospital admission data, excluding dialysis
patients (60% of whom are Indigenous), as
they are admitted three times per week and
would skew the data. Patients presenting to
the ED are entered into a different database
as only some are admitted. All patients
presenting with epilepsy or seizure were
recorded. Indigenous status is routinely
recorded by hospital administrative staff.
EEG laboratory data
The EEG service at CBH for neonates, chil-
dren and adults has been operating since
2002. It uses a database reporting system,
which routinely records demographic
information, including Indigenous status.
To facilitate analysis, EEG diagnoses were
grouped into broad categories, reflecting
clinically useful classifications. Epileptiform
abnormalities included definite sharp waves
or sharp- and slow-wave complexes, and
were grouped as: “generalised” (consistent
with idiopathic generalised epilepsy), “focal
frontotemporal”, “focal non-temporal”, orJA • Volume 184 Number 12 • 19 June 2006 607
RESEARCH“other” (including multifocal discharges,
secondary generalised activity such as slow
spike and wave, and electrographic status).
Non-epileptiform abnormalities included
focal or diffuse slowing and triphasic waves.
Epilepsy clinic data
An epilepsy clinic has been operating at
CBH since 2002. All patients are seen by the
same neurologist (J A). Indigenous status is
checked, if not already recorded, by direct
questioning of the patient. An epilepsy his-
tory is obtained from each patient, covering
epileptic auras, features suggesting focality
at seizure onset, eyewitness descriptions of
seizures, history of head trauma causing loss
of consciousness, and current alcohol intake
(standard drinks per week).
At the completion of each clinic, informa-
tion is entered into the database, including
demographic characteristics, seizure type
and frequency, and results of key investiga-
tions. The likely epilepsy syndrome is
recorded according to International League
Against Epilepsy (ILAE 2001) criteria.
Although EEG information is used to aid
classification, syndrome diagnosis is some-
times made in the absence of definitive EEG
abnormalities (eg, with recent development
of myoclonic jerks and seizures, which are
tonic–clonic from the outset, in an intellec-
tually normal adolescent, a diagnosis of
idiopathic generalised epilepsy would be
made even if EEG gave normal results).
Statistical methods
Descriptive statistics were used for common
ratios, χ2 testing for nominal data of suffi-
cient sample size, and unpaired Student’s t
tests for continuous data. Statistical analysis
was performed using StatView version 5.0.1
(SAS Institute, Cary, NC, USA).
Ethical approval
The study was approved by the ethics




Between 2001 and 2004, there were 418
admissions to CBH with a diagnosis of
epilepsy; 31% (130/418) were Indigenous
patients. This can be compared with the
population of the hospital catchment area
(13% Indigenous people) and that of gen-
eral CBH admissions (20% Indigenous peo-
ple). Over the same period, 44% of those
admitted with status epilepticus (n = 63)
were Indigenous. The over-representation of
Indigenous people in this group is more
evident in the subgroup of adults (> 18
years) with status epilepticus (n = 40), of
whom 53% were Indigenous.
Emergency department
In 2004, 486 patients presented to the ED
with an acute seizure (coded with a dia-
gnosis of “postictal”, “seizure”, or “status epi-
lepticus”), of whom 30% were Indigenous;
17% of all general admissions to the ED over
the same period were Indigenous patients.
Epilepsy clinic and EEG service
From 1 September 2002 to 31 March 2005,
359 patients were seen in the epilepsy clinic,
of whom 11% (n = 40) were Indigenous,
87% (n = 313) non-Indigenous, and 2%
(n = 6) of unknown status. Over a similar
period, 13% (118/918) of the EEGs per-
formed were on Indigenous patients. These
figures compare favourably with the
expected proportion of Indigenous people
in the catchment population. Indigenous
patients attending the clinic were signifi-
cantly younger (P = 0.025, unpaired t test),
with a pronounced peak between the ages of
10 and 30 years. Non-Indigenous patients
attending the clinic were spread more evenly
across the age spectrum (Box 1); 53% of
both Indigenous and non-Indigenous
patients attending the clinic were female.
Non-Indigenous patients (compared with
Indigenous patients) presenting to the epi-
lepsy clinic were more likely to receive a
diagnosis of a non-epileptic disorder (31% v
18%), although this difference was not sig-
nificant. Non-epileptic attacks included syn-
cope, panic attacks and pseudoseizures.
However, converging results come from the
finding that non-Indigenous patients were
more likely to have normal EEG results
(58% v 47%; P = 0.025; Fisher’s exact χ2 test)
(Box 2).
For patients attending the epilepsy clinic
who were diagnosed with epilepsy, the pro-
portions of Indigenous and non-Indigenous
patients in the main syndrome groupings
were remarkably similar. In a parallel find-
ing, Indigenous and non-Indigenous
patients with abnormal EEG findings
showed similar proportions of the different
abnormalities (Box 3). A crude estimation of
seizure burden was calculated by adding
annual seizure frequency for each seizure
type for each patient. This can be quite
1 Age distribution of patients 
presenting to the epilepsy clinic
Presentations of Indigenous people are 
significantly skewed towards younger ages 
(P = 0.025, unpaired t test). Children are under-








Non-Indigenous (n = 313)
Indigenous (n = 40)
70-7960-6950-5940-4930-3920-2910-190-9
Age group (years)
2 Classification of patients attending 
the electroencephalography (EEG) 





Normal 465 (58%) 56 (47%)
Abnormal 332 (42%) 62 (53%)
Total 797 (100%) 118 (100%)
Indigenous patients were more likely to have an 
abnormal EEG (P = 0.025, Fisher’s exact χ2 test). ◆
3 Classification of patients 
presenting to the epilepsy clinic 
(excluding non-epileptic 
presentations)
IGE = idiopathic generalised epilepsy. 
TLE = temporal lobe epilepsy.
Non-TLE focal = focal epilepsy not arising from the 
temporal lobe. 






Non-Indigenous (n = 216)
Indigenous (n = 33)
Uncertain2°GENon-TLE focalTLEIGE
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absences, which may not always be
detected, and myoclonic seizures which
may be erratic, frequent and occur in clus-
ters. Within these limitations, no significant
difference in seizure burden was noted
between Indigenous and non-Indigenous
patients.
Sixty per cent of Indigenous patients and
56% of non-Indigenous patients attending
the clinic had cerebral imaging performed
or already available. Reasons for not per-
forming imaging included non-epileptic
attacks, idiopathic generalised epilepsy, or
patient non-compliance. Twenty per cent of
Indigenous patients and 17% of non-Indi-
genous patients were found to have abnor-
malities on CT or MRI scans that could
account for their epilepsy syndrome (Box 4).
Epileptogenic abnormalities in both groups
included ischaemic injury, tumour, dyspla-
sia, hippocampal sclerosis and post-trau-
matic gliosis. That there was no significant
difference in the rate of reported head injury
(13% non-Indigenous patients v 18% Indi-
genous) collaborated these findings. Alcohol
was consumed by 38% of non-Indigenous
and 37% of Indigenous patients with epi-
lepsy (Box 5). There was no significant differ-
ence in the amount of alcohol being
consumed among those currently drinking,
although subject numbers were small.
DISCUSSION
Aboriginal and Torres Strait Islander
patients presenting to CBH with epilepsy
have similar epilepsy syndromes to non-
Indigenous patients, but the condition in
Indigenous patients at presentation is more
serious. Although the proportion of Indi-
genous patients presenting to the epilepsy
clinic or for EEG appointments is the same
as in the catchment population, they are
over-represented among ED presentations
and inpatient admissions. This increase
(about 30% of those presenting with epi-
lepsy) exceeds the Indigenous over-repre-
sentation seen at the hospital (about 20% of
presentations). The situation is more
marked with the most severe of epilepsy
presentations — status epilepticus — where
Indigenous patients comprise 44% of pres-
entations, rising to 53% of the subgroup of
adults with status epilepticus. Thus, there is
a gradient of progressive over-representa-
tion, moving from the mild to more severe
epilepsy presentations. However, data from
the EEG laboratory, which serves both inpa-
tients and outpatients, and the epilepsy
clinic suggest that rates of basic syndromic
classification are similar. The proportion of
epilepsy patients with idiopathic generalised
epilepsy, which probably has a largely
genetic basis, was similar at about 20% in
both groups. Temporal lobe epilepsy, which
can have an environmental contribution
through prolonged febrile convulsions of
early childhood, also showed similar rates of
about 20% in the Indigenous and non-
Indigenous groups.
It is a commonly held belief among those
working with Indigenous people that most
cases of epilepsy are due to the effects of
alcohol excess and head trauma. Our find-
ings of similar rates of epileptogenic abnor-
malities seen on structural imaging provide
no evidence to support this belief. The rate
of structural abnormalities is slightly higher
than that seen in series from first seizure
clinics (about 13%),15 but this is probably
accounted for by the mixture of patients in
our study, which includes those with refrac-
tory epilepsy in whom brain lesions are
more commonly observed. A very similar
percentage of Indigenous and non-Indi-
genous patients presenting to the epilepsy
clinic consumed alcohol. It is not possible to
say that alcohol does not contribute to epi-
lepsy in Indigenous patients, as our study is
not primarily designed to answer this ques-
tion, but our data suggest that alcohol is
relevant in a minority of Indigenous patients
with epilepsy.
Of the several possible reasons for the
more severe epilepsy presentations in Indi-
genous patients, the most likely relate to
inequalities in health care utilisation. Indi-
genous Australians, for a variety of reasons
including cultural issues and geographic
isolation, are less likely to consult a medical
practitioner.16,17 Despite recent attempts to
improve relationships between Indigenous
Australians and government bodies, a his-
tory of mistrust leads to reluctance to seek
help. Added to this are fewer doctors and
often only a fly-in service in more remote
regions. In some instances, there seems to
be a “learned helplessness”, perhaps tied in
with low socioeconomic status and lowered
expectations from life. Some Indigenous
Australians simply put up with medical
conditions, such as intermittent seizures,
that their non-Indigenous compatriots
would seek help for. This may also be
related to reduced medication compliance,
but this is a complex issue. Reduced com-
pliance can result from inadequate explan-
ations from medical staff, and financial
or geographical difficulty in obtaining medi-
cation.
Racial variation in epilepsy has been
examined in the United States, which
appears to show a modestly increased (1.7
times higher) incidence of epilepsy in Afri-
can American children.18 The same study
also examined the effect of socioeconomic
class, showing that, after controlling for
race, the incidence of epilepsy remained
significantly higher in people of lower socio-
economic status.18 Similar socioeconomic
effects have been reported in the UK, where
a 2.3-fold increase in epilepsy incidence
was seen in the lowest fifth compared
with the highest fifth of the socioeco-
nomic spectrum.19 It is unclear whether
5 History of head injury causing loss 
of consciousness, or alcohol 





No (n = 293) 261 (87%) 32 (82%)
Yes (n = 47) 40 (13%) 7 (18%)
Total 301 (100%) 39 (100%)
Alcohol consumption
No (n = 177) 153 (62%) 24 (63%)
Yes (n = 107) 93 (38%) 14 (37%)
Total 246 (100%) 38 (100%)
Totals for head injury and alcohol consumption 
differ, as patients with inadequate documentation 
of these variables are not included in the analysis.◆
4 Proportion of patients treated in 
the epilepsy clinic in whom 
abnormalities* were detected on 







Normal 105 (34%) 15 (38%)
Epileptogenic 
abnormality




16 (5%) 1 (3%)
No information 139 (44%) 16 (40%)
* Epileptogenic abnormalities include hippocampal 
sclerosis; tumours; porencephaly from stroke, 
trauma or neurosurgery; and malformations of 
cortical development. CT = computed tomography; 
MR = magnetic resonance. ◆MJA • Volume 184 Number 12 • 19 June 2006 609
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an epiphenomenon.
Our study does not provide data on inci-
dence or prevalence of epilepsy in Indi-
genous and non-Indigenous people in the
tropical north of Australia. However, it does
provide fairly robust information on epi-
lepsy syndromes in the individuals seen. We
cannot exclude the possibility that, at a
community level, there is an increased rate
of epilepsy among Indigenous people, and
that clinic presentation rates falsely appear
proportional to the population due to
under-presentation. However, counteracting
this effect, non-Indigenous people are more
likely to seek neurology care outside the
public sector. It is clear from expected inci-
dence and prevalence data that we are not
seeing all cases of epilepsy in the region.
But, as I am the sole neurology practitioner
for this region, providing the only EEG
service, it is likely this is a reasonably repre-
sentative sample of epilepsy presentations.
Our study suggests that there is a role for
improved epilepsy education among Indi-
genous Australians, Indigenous health
workers and medical practitioners working
in the area. For clinicians working with
Indigenous people, extra time may need to
be allocated to ensure explanations and
medication advice are delivered in a cultur-
ally sensitive fashion. In the longer term,
there is a need to improve accessibility of
epilepsy services for Indigenous Australians.
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